Evidence map›Paper›PMID 37865636›Full record

ArticleNature communications2023

Ultra-high-throughput mapping of the chemical space of asymmetric catalysis enables accelerated reaction discovery.

Wenjing Nie, Qiongqiong Wan, Jian Sun, Moran Chen, Ming Gao, Suming Chen

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Considerations in Pursuing Reaction Scope Generality.Angewandte Chemie (International ed. in English) · 2025
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenjing NieThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, 430072, China.
Qiongqiong WanThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, 430072, China.
Jian SunThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, 430072, China.
Moran ChenThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, 430072, China.ORCID http://orcid.org/0000-0001-7608-9062
Ming GaoThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, 430072, China.
Suming ChenThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, 430072, China. sm.chen@whu.edu.cn.ORCID http://orcid.org/0000-0002-8017-0282

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22004093National Natural Science Foundation of China (National Science Foundation of China) 22074111
6 · The paper itself

Abstract

The discovery of highly enantioselective catalysts and elucidating their generality face great challenges due to the complex multidimensional chemical space of asymmetric catalysis and inefficient screening methods. Here, we develop a general strategy for ultra-high-throughput mapping of the chemical space of asymmetric catalysis by escaping the time-consuming chiral chromatography separation. The ultrafast ( ~ 1000 reactions/day) and accurate (median error < ±1%) analysis of enantiomeric excess are achieved through the ion mobility-mass spectrometry combines with the diastereoisomerization strategy. A workflow for accelerated asymmetric reaction screening is established and verified by mapping the large-scale chemical space of more than 1600 reactions of α-asymmetric alkylation of aldehyde with organocatalysis and photocatalysis. Importantly, a class of high-enantioselectivity primary amine organocatalysts of 1,2-diphenylethane-1,2-diamine-based sulfonamides is discovered by the accelerated screening, and the mechanism for high-selectivity is demonstrated by computational chemistry. This study provides a practical and robust solution for large-scale screening and discovery of asymmetric reactions.

Identifiers

PMID37865636
PMCPMC10590410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.